Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Kettle

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nuclear Medicine Communications|June 13, 1998
Can chest X-rays and ventilation/perfusion scans be interpreted reliably from personal computer screens?E R Denton, S F Barrington, A G Kettle, et al.
Nuclear Medicine Communications|March 1, 1993
Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosisM J O'Doherty, A G Kettle, C N Eustance, et al.
Nuclear Medicine Communications|May 1, 1996
Radiation protection issuesM J O'Doherty, S F Barrington, A G Kettle, et al.
Nuclear Medicine Communications|July 1, 1992
123I-methylene blue: an unsatisfactory parathyroid imaging agentP J Blower, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|November 1, 1989
99Tcm sestamibi--a new agent for parathyroid imagingA J Coakley, A G Kettle, C P Wells, et al.
Nuclear Medicine Communications|March 27, 1998
The value of the chest radiograph in reporting aerosol ventilation-perfusion scansE R Denton, S F Barrington, A G Kettle, et al.
European Journal of Nuclear Medicine|February 1, 1996
Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroidS F Barrington, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|December 1, 1995
Home reporting for the nuclear clinician?M J O'Doherty, A G Kettle, N J Bird, et al.
Nuclear Medicine Communications|December 11, 1997
Pentavalent 99Tcm-DMSA imaging in patients with bone metastasesA S Lam, A G Kettle, M J O'Doherty, et al.
European Journal of Nuclear Medicine|June 10, 1998
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studiesP J Blower, A S Lam, M J O'Doherty, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nuclear Medicine Communications|June 13, 1998
Can chest X-rays and ventilation/perfusion scans be interpreted reliably from personal computer screens?E R Denton, S F Barrington, A G Kettle, et al.
Nuclear Medicine Communications|March 1, 1993
Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosisM J O'Doherty, A G Kettle, C N Eustance, et al.
Nuclear Medicine Communications|May 1, 1996
Radiation protection issuesM J O'Doherty, S F Barrington, A G Kettle, et al.
Nuclear Medicine Communications|July 1, 1992
123I-methylene blue: an unsatisfactory parathyroid imaging agentP J Blower, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|November 1, 1989
99Tcm sestamibi--a new agent for parathyroid imagingA J Coakley, A G Kettle, C P Wells, et al.
Nuclear Medicine Communications|March 27, 1998
The value of the chest radiograph in reporting aerosol ventilation-perfusion scansE R Denton, S F Barrington, A G Kettle, et al.
European Journal of Nuclear Medicine|February 1, 1996
Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroidS F Barrington, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|December 1, 1995
Home reporting for the nuclear clinician?M J O'Doherty, A G Kettle, N J Bird, et al.
Nuclear Medicine Communications|December 11, 1997
Pentavalent 99Tcm-DMSA imaging in patients with bone metastasesA S Lam, A G Kettle, M J O'Doherty, et al.
European Journal of Nuclear Medicine|June 10, 1998
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studiesP J Blower, A S Lam, M J O'Doherty, et al.
Pageof 3